Fifth Street Finance Corp. Welcomes Casey Zmijeski to the Partnership of its Investment Adviser - June 28, 2010

ADVENTRX Added to Russell Microcap Index - June 28, 2010

NeoStem Raises $5 Million in Registered Direct Offering - June 25, 2010

Abitex and Continental Nickel intersect new sulphide zones at the St. Stephen project in New Brunswick - June 23, 2010

GFI Group Inc. to Acquire The Kyte Group Limited and Kyte Capital Management Limited, Providers of Clearing, Broking, Investment Services and Seed Capital to Financial Market Traders - June 21, 2010

Fifth Street Finance Corp. Raises $105.8 Million in Gross Proceeds in Connection With Public Offering of Common Stock  - June 21, 2010

TOMI Environmental Solutions Offers Immigrant Investor Visa Program - June 18, 2010

Vical's Allovectin-7(R) Phase 3 Trial Receives Positive Review From Safety Monitoring Board - June 16, 2010

AMERICAN NATIONAL ANNOUNCES NEW PRESIDENT - June 16,, 2010

TOMI Environmental Solutions Announces the Formation of Its Singapore Subsidiary - June 15, 2010

Fifth Street Finance Corp. Commences Public Offering of Common Stock - June 15, 2010

PV-10 for Melanoma Clinical Trial Gaining Media Attention - June 14, 2010

Video of Provectus Presentation at the SCIA Summer Conference Available - June 14, 2010

Rodman & Renshaw ASCO 2010 Review Note Covers Provectus - June 11, 2010

RXi Pharmaceuticals Announces New Focused Therapeutic Strategy for its Next Generation RNAi Technology  - June 10, 2010

Video of Dr. Agarwala's June 7 Presentation On PV-10 For Melanoma Available  - June 10, 2010

Provectus Among ASCO 2010 Winners  - June 10, 2010

Manitex International, Inc. Receives $5 Million in New Orders - June 9, 2010

Maxim Group Issues Company Update on Provectus Following Positive ASCO Presentation  - June 9, 2010

Provectus Reports Encouraging Data on Visceral Metastases Presented at ASCO  - June 7, 2010

Vical to Present at Two Upcoming Investor Conferences - June 7, 2010

Brandywine Realty Trust’s Two Barton Skyway and South Point I Buildings Both Earn Prestigious
EPA Energy Star Award - June 3, 2010

Philips and RXi Pharmaceuticals Sign Agreement to Jointly Research Innovative Image-Guided Therapy Concepts Based on RNAi  - June 3, 2010

Fifth Street Finance Corp. Closes Three-Year Credit Facility Led by ING Capital - June 3, 2010

Brandywine Realty Trust Announces Quarterly Dividends and
Confirms Second Quarter 2010 Earnings Release and Conference Call - June 2, 2010

RXi Pharmaceuticals CEO to Present at the Jefferies 2010 Global Life Sciences Conference - June 2, 2010

Vical to Present at Three Upcoming Investor Conferences - June 1, 2010

Fifth Street Finance Corp. Announces Improved Pricing and Expansion of Credit Facility With Wells Fargo - May 27, 2010

Vical Collaborators Receive Grant to Pursue Novel CMV Vaccine Strategies - May 25, 2010

Maxim Group Issues Company Update on Provectus - May 21, 2010

Provectus Reports Further Positive Phase 2 Data on PV-10 for Metastatic Melanoma at ASCO - May 21, 2010

Medical Technology Stock Letter Recommends Provectus as a Buy - May 20, 2010

Gold-Ore Begins Trading On TSX Senior Board - May 17, 2010

RXi Pharmaceuticals Reports Financial Results for the First Quarter of 2010  - May 17, 2010

Allovectin-7(R) Achieves Median Survival of Nearly 19 Months in Phase 2 Melanoma Trial - May 12, 2010

Vical to Present at Rodman & Renshaw Global Healthcare Conference - May 11, 2010

RXi Pharmaceuticals CEO to Present at the Rodman & Renshaw Annual Global Healthcare Conference  - May 11, 2010

Fifth Street Finance Corp. Announces Improved Financing Terms on ING Credit Facility - May 7, 2010

Vical Reports First Quarter 2010 Financial Results and Progress in Key Programs - May 6, 2010

Vical Begins Phase 1 Trial of DNA Vaccine Against H1N1 Pandemic Influenza - May 5, 2010

RXi Demonstrates Robust in vivo Uptake and Significant Silencing Using its Self-Delivering rxRNA™ Compounds Administered to Mouse Retinal Cells  - May 4, 2010

Fifth Street Finance Corp. Increases Its 2010 Third Quarter Dividend to $0.32 Per Share - May 4, 2010

ABITEX COMPLETES FIRST TRANCHE OF PRIVATE PLACEMENT RAISING $2,844,281 - May 3, 2010

Maxim Group Issues Company Update on Provectus  - April 30, 2010

Vical CEO Selected as Panelist at BIO and PGH Conferences - April 30, 2010

Vical Announces News Release and Conference Call Schedule for First Quarter 2010 Financial Results - April 29, 2010

Provectus Reports on Successful End-of-Phase 2 Meeting with U.S. FDA and Gains Clarity for Licensure of PV-10 for Metastatic Melanoma  - April 29, 2010

Bio-Solutions Corp. Accepts Invite Back to Mali - April 28, 2010

Brandywine Realty Trust Announces First Quarter 2010 Earnings
Raises 2010 FFO Guidance Range to $1.27 to $1.34 per Diluted Share - April 28, 2010

Vical Reports Encouraging Updates From U.S. Military Malaria Vaccine Programs - April 27, 2010

Provectus Pharmaceuticals, Inc. (PVCT.OB) INVITES YOU to an UPDATE - April 27, 2010

California United Bank Announces 32.1% Increase in Total Deposits, 17.3% Increase in Net Income for 1st Quarter 2010 - April 23, 2010

TOMI Environmental Solutions Announces CEO Interview - April 23, 2010

Vical Presents Encouraging Preliminary Data From Final 12-month Follow-up in TransVax(TM) CMV Vaccine Phase 2 Transplant Recipient Trial - April 22, 2010

American National Bankshares Inc. and Subsidiaries  Consolidated Balance Sheets
April 21, 2010

AMERICAN NATIONAL BANKSHARES Inc. REPORTS First QUARTER 2010 earnings - April 21, 2010

Brandywine Realty Trust Executes 334,300 Square Foot Lease
Renewal with Wells Fargo Bank at Concord Airport Plaza - April 21, 2010

1st Enterprise Bank Grows to $400 Million in Assets - April 20, 2010

RXi Pharmaceuticals Presents at AACR Conference, Highlighting the Potential for RNAi Therapeutics in Oncology - April 19, 2010

Fifth Street Finance Corp. Releases Its Monthly Newsletter, April 2010 - April 14, 2010

Fifth Street Finance Corp. Recognized as "Lender of the Year" for 2009 From Mergers & Acquisitions Journal - April 13, 2010

Fifth Street Finance Corp. Schedules Quarterly Earnings Release for the Period Ended March 31, 2010 - April 12, 2010

RXi Pharmaceuticals and miRagen Therapeutics Announce Formation of Research Collaboration in the Field of microRNA  - April 12, 2010

RXi Pharmaceuticals Announces Formation of microRNA Research Collaboration with Mirna Therapeutics  - April 12, 2010

Fifth Street Finance Corp. Announces Staff Additions and Promotions - April 12, 2010

Maxim Group Updates Reseach Note on Provectus  - April 8, 2010

MORO CORPORATION REPORTS FULL YEAR 2009 EARNINGS PER SHARE INCREASES 143% OVER PREVIOUS YEAR - April 7, 2010

RXi Pharmaceuticals and miRagen Therapeutics Announce Formation of Research Collaboration in the Field of microRNA  - April 12, 2010

RXi Pharmaceuticals Announces Formation of microRNA Research Collaboration with Mirna Therapeutics  - April 12, 2010

Fifth Street Finance Corp. Announces Staff Additions and Promotions - April 12, 2010

Maxim Group Updates Reseach Note on Provectus  - April 8, 2010

MORO CORPORATION REPORTS FULL YEAR 2009 EARNINGS PER SHARE INCREASES 143% OVER PREVIOUS YEAR - April 7, 2010

RXi Pharmaceuticals and TransDerm Announce Formation of Research Collaboration  - April 6, 2010

RXi Pharmaceuticals CEO to Present at the Future Leaders in the Biotech Industry Investment Conference  - April 1, 2010

RXi Pharmaceuticals Reports Fourth Quarter and 2009 Financial Results  - Mareh 31, 2010

RXi Pharmaceuticals to Host Year-End 2009 Earnings Conference Call and Webcast on Wednesday, March 29, 2010

RXi Pharmaceuticals to Present New Preclinical Data Demonstrating the Robust Performance of its RNAi Therapeutics Platform  - March 25, 2010

Provectus Pharmaceuticals to Present at CFA Society of Nevada on March 31, 2010  - March 24, 2010

Brandywine Realty Trust Announces Quarterly Dividends - March 24, 2010

Beacon Enterprise Solutions Signs Strategic Global Partnership with Atlas Industrial Electric  - March 23, 2010

Vical Secures Funding to Proceed With Phase 1 Trial of H1N1 Pandemic Influenza Vaccine - March 22, 2010

Phase 2 Data on Provectus's PV-10 To Be Presented at the 2010 ASCO Scientific Program on June 4 - 8 in Chicago  - March 18, 2010

Brandywine Realty Trust Announces 2010 Quarterly Earnings Release Dates and
Conference Calls - March 16, 2010

Data Highlights Involvement of Immune System in Response to Provectus's PV-10 Therapy and Its Role in the Bystander Effect  - March 15, 2010

Beacon Enterprise Solutions Extends Offer for Outstanding Warrants  - March 12, 2010

Fifth Street Finance Corp. Releases Its Monthly Newsletter, March 2010 - March 11, 2010

Provectus Pharmaceuticals Executes Purchase Agreements for Approximately $5.3 Million Private Placement  - March 9, 2010

Dr. Sanjiv Agarwala to Present Update on Provectus' PV-10  - March 8, 2010

Beacon Enterprise Solutions Announces Two New Engagements with Consumer Companies - March 8, 2010

Vical to Present at Upcoming Investor Conferences - March 1, 2010

California United Bank Announces Positive Fourth Quarter
Performance and Strong 2009 Results - February 28, 2010

Fifth Street Finance Corp. Promotes Bernard D. Berman to President and Announces New Board Member - February 25, 2010

Fifth Street Finance Corp. Receives Long Term Financing Commitment of Up to $150 Million - February 25, 2010


Brandywine Realty Trust Announces Fourth Quarter and Full Year 2009 Earnings - February 24, 2010

Publication of Vical's H5N1 Results Paves the Way for H1N1 Clinical Trial - February 24, 2010

AMERICAN NATIONAL BANKSHARES INC. (VA) ANNOUNCES SHELF REGISTRATION - February 19, 2010

AMERICAN NATIONAL BANKSHARES INC. (VA) ANNOUNCES FIRST QUARTER 2010 CASH DIVIDEND - February 17, 2010

Vical Reports 2009 Financial Results and Progress in Key Development Programs - February 11, 2010

Fifth Street Finance Corp. Announces Quarter Ended December 31, 2009 Financial Results - February 9, 2010

Brandywine Realty Trust Executes 641,433 Square Feet of Leasing in Fourth Quarter 2009 - February 8, 2010

Vical Announces News Release and Conference Call Schedule for 2009 Financial Results - February 4, 2010

First State Reports Fourth Quarter Results - February 1, 2010

Vical Completes Enrollment in Allovectin-7(r) Phase 3 Trial for Metastatic Melanoma - January 28, 2010

New First State Chairman and CEO Confirmed - January 28, 2010

Fifth Street Finance Corp. Raises $78.4 Million in Gross Proceeds in Connection With Public Offering of Common Stock - January 27, 2010

MegaWest to Participate in Scottsdale Investment Conference - January 26, 2010

Brandywine Realty Trust Names George S. Hasenecz
Senior Vice President, Investments - January 26, 2010

Vical Updates Vaccine Development Programs for CMV and Pandemic Influenza - January 26, 2010

KAT Exploration-Hand Camp Soil samples submitted for Analysis. - January 25, 2010

Fifth Street Finance Corp. Prices Public Offering of Common Stock - January 22, 2010

AMERICAN NATIONAL BANKSHARES Inc. REPORTS FOURTH QUARTER 2009 earnings  - January 21, 2010

American National Bankshares Financials - January 21, 2010

Fifth Street Finance Corp. Issues Preliminary Estimate of Net Investment Income and Announces Term Sheet for an Additional Credit Line - January 21, 2010

Brandywine Realty Trust Announces Tax Characteristics of Its 2009 Distributions - January 21, 2010

Brandywine Realty Trust Announces Lease with “Iron Chef” Jose Garces at Cira Centre - January 19, 2010

ABITEX REPORTS 4.93% eU3O8 OVER 5.2 METERS ON LAVOIE PROPERTY - January 14, 2010

Vical Names Richard T. Kenney, M.D., Vice President of Clinical Development - January 14, 2010

Fifth Street Finance Corp. Receives SBA Committee Approval for its Subsidiary's SBIC License - January 13, 2010

American CareSource Holdings and ChiroSource Inc. Sign National Agreement  - January 13, 2010

Vical Announces Licensee's Approval of ONCEPT(TM) Therapeutic Melanoma Vaccine for Dogs - January 11, 2010

Vical Secures $25 Million Issuer Managed Equity Facility With Azimuth Opportunity, Ltd. - January 8, 2010

ABITEX REPORTS FINAL U-AU RESULTS FOR EPSILON-B - January 7, 2010

Mechanism of Action for Vical's Vaxfectin(R) Adjuvant Expands Potential Applications - January 7, 2010

Fifth Street Finance Corp. Announces Waiver of Management Fee and Other Shareholder-Friendly Actions - January 6, 2010

Concert Pharmaceuticals to Present at the 28^th Annual J.P. Morgan Healthcare Conference on Monday, January 11  - January 4, 2010

Fifth Street Finance Corp. Announces the Structuring of $208.8 Million of Senior Secured Debt Financings - January 1, 2010